Kerstin A. David
Directeur Technique/Scientifique/R&D chez Indivumed GmbH
Profil
Kerstin A.
David is currently the Chief Scientific Officer at Indivumed GmbH.
Prior to this, she worked as an Assistant Professor at the University of Hamburg and the Cancer Research Center of Hawaii.
She holds a doctorate degree from the University of Hamburg.
Postes actifs de Kerstin A. David
| Sociétés | Poste | Début |
|---|---|---|
Indivumed GmbH
 Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Directeur Technique/Scientifique/R&D | 01/01/2002 |
Anciens postes connus de Kerstin A. David
| Sociétés | Poste | Fin |
|---|---|---|
| Cancer Research Center of Hawaii | Corporate Officer/Principal | - |
| University of Hamburg | Corporate Officer/Principal | - |
Formation de Kerstin A. David
| University of Hamburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Indivumed GmbH
Indivumed GmbH Data Processing ServicesTechnology Services Indivumed GmbH engages in the research and development of medical treatment for cancer patients. The firm develops an integrated analytical platform, which links sample sets from cancer patients such as tissue types, serum, plasma, and urine with a web-accessible database. It offers treatment for the people suffering from GI-tract such as colorectal, gastric, pancreatic, breast, and lung cancer. The company was founded by Hartmut Juhl, Carsten Zornig and Peter Layer in April 2002 and is headquartered in Hamburg, Germany. | Technology Services |
| Cancer Research Center of Hawaii |
